VLP-vaccinetestning Danmark

• Insights on VLP vaccine's clinical trials

  Development and testing of new vaccines is a lengthy process that requires detailed work. New vaccines are generally tested across four different phases of clinical trials, scientists explained. Over time, more and more people get the vaccine in each phase to determine how efficacious it is and whether or not there are any adverse side effects which could be harmful.

• Investigating VLP vaccine's efficacy against infectious diseases

  VLP vaccines are being explored for a variety of diseases by scientists. An example is a VLP vaccine for Zika virus. This virus also puts pregnant women at risk, as it can produce severe consequences for babies if their mothers were to become infected. The hope is that the VLP vaccine will stop pregnant women and their babies from getting sick.

• The future of VLP vaccine testing

  Scientists are also testing VLP vaccines for Ebola, another deadly disease. A deadly virus like the Ebola one creates outbreaks and can spread throughout virtually any region, especially Africa. By creating VLP vaccines that are developed to reduce the hot transmission of Ebola; scientists need some information about developing skin-saving and life, recruiting many people from growing list.

Why choose Yaohai VLP Vaccine Testing?

• Robust forsyningskæde og produktionskapacitet

  Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have established an advanced facility that is equipped with modern facilities and strong RD manufacturing capabilities. We have five drug substance manufacturing lines that are in compliance with GMP requirements for microbial fermentation and purification, as well as two fill-finish lines that are automated for cartridges, vials, as well as pre-filled syringes. The available fermentation scales vary from 100L to 500L, 1000L and 2000L. VLP Vaccine Testing for vias are 1ml to 25ml, whereas the pre-filled syringes and cartridge filling specifications cover 1-3ml. Our production workshop is cGMP compliant and guarantees steady supply of clinical samples as well as commercial items. Our plant produces large molecules which are shipped to the globe.

• Professionel ekspertise og bred erfaring

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to manage the health of pets, humans and animals. health. We have modern RD and manufacturing technology platforms that cover the entire process, from microbial strain engineering, cell banking, process and method design to commercial and clinical manufacturing, which ensures the success supply of the most cutting-edge solutions. Through the years we have gained vast expertise in using microbial sources. Over 200 projects were successfully completed. In addition, we support our clients in get through regulations, such as those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. Our expert knowledge and vast experience allow us to quickly respond to market demands and provide VLP Vaccine Testing CDMO services.

• Kvalitetssystem og overholdelse af global lovgivning

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have a quality system which is in line with current GMP standards and international regulations. Our regulatory team is knowledgeable in global regulatory frameworks to accelerate biological launches. We ensure traceable manufacturing processes and top-quality products that are compliant with the requirements of the US FDA, EU EMA, Australia TGA, and VLP Vaccine Testing. Yaohai BioPharma has successfully passed the audit on site of the European Union's qualified Person (QP) for our GMP quality system and production site. In addition, we've cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Tilpasning, effektivitet og omkostningseffektivitet

  Yaohai Bio-Pharma is experienced in biologicals derived from microbial sources. We provide customized RD solutions and manufacturing, while minimising potential risks. We have worked on various modalities, including recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies enzymes, plasmid DNA various mRNAs, and more. We have specialized in multiple microorganisms, including VLP Vaccine Testing intracellular and extracellular secretion (yields up to 15g/L) and intracellular soluble bacteria and inclusion body (yields up to 10g/L). We have also established a BSL-2 fermentation platform to create bacteria-based vaccines. We are experts in improving processes, boosting product yields, and decreasing production costs. We have a highly efficient technology team that ensures timely and top-quality project delivery. This allows us to bring your unique products faster to market.

Relaterede produktkategorier

Kan du ikke finde det, du leder efter?
Kontakt vores konsulenter for flere tilgængelige produkter.